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ABSTRACT
Introduction: Haemoglobin A
1C
 (A
1C
), as a parameter of long-term glycaemic control, has been adopted to guide diabetic therapy all over the 
world. However, falsely high or low A
1C
 could be troublesome in daily practice. 
Case description: A 75-year-old male diabetic patient affected by a reasonably inferred life-long history of microcytic anaemia was found 
to have abnormally low A
1C
 values in the previous 5 months. Subsequent laboratory assessment with brilliant cresyl blue staining and 
haemoglobin electrophoresis detected haemoglobin H disease as the underlying cause of both the microcytic anaemia and the disturbed 
A
1C
 measurement. 
Discussion: Enhanced erythrocyte destruction such as in haemoglobin H disease could explain a falsely decreased A
1C
 level very well. Upon 
facing a questionable A
1C
 value, physicians dealing with diabetes should consider the possibility of undiscovered underlying causes rather 
than too tightly glycaemic control.  
LEARNING POINTS
• Haemoglobin A
1C
 values lower than the normal range most likely do not mean too good a control of blood sugar in diabetic patients.
•	 Careful	investigation	to	find	the	underlying	causes	is	mandatory	to	provide	well-qualified	medical	care.
• Various haemoglobinopathies with chronic haemolysis should be considered as the background reason, especially in an endemic area for 
thalassaemia.
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INTRODUCTION
Haemoglobin HbA
1C
 (A
1C
) levels have been widely recognized as being a reliable estimate of long-term blood sugar levels, particularly in 
evaluating	the	efficacy	of	glycaemic	control	in	diabetic	patients.	Nevertheless,	abnormally	increased	or	decreased	A
1C 
levels may be detected 
due	to	various	underlying	pathologic	causes,	chiefly	including	altered	erythropoiesis	rates,	erythrocyte	destruction,	haemoglobinopathy,	
alcoholism, chronic renal failure, splenomegaly, hyperbilirubinaemia, hypertriglyceridaemia and certain drugs[1]. Herein, we would like to 
present a case involving an elderly diabetic patient with moderately severe microcytic anaemia and persistently low A
1C
 levels which had 
been initially misunderstood as representing over-strict glycaemic control. Disclosing the underlying cause of abnormally decreased A
1C
 
levels may act as a reminder to the physician in charge of the necessity of using alternative tests other than A
1C 
measurement in guiding 
diabetic management. 
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CASE PRESENTATION 
A 75-year-old man was brought to our outpatient clinic from a nearby nursing home with the chief complaint of progressive dizziness and 
weakness for several weeks. Fever, nausea, vomiting, abdominal pain, dark urine, haematemesis, melaena and haematochezia were all 
denied.
The patient had been on regular medication for medically controlled hypertension and gouty arthritis in the past 2 years. Type 2 diabetes 
was	diagnosed	based	on	elevated	fasting	and	postprandial	plasma	sugar	levels	1	year	previously.	Dapagliflozin	and	repaglinide	had	been	
prescribed	ever	since.	His	surgical	history	included	appendectomy	and	fixation	of	a	right	femoral	intertrochanteric	fracture	more	than	8	
years previously.
On physical examination, a pale conjunctiva and tachycardia, 111 regular beats per minute, with mild systolic murmur, were the most notable 
findings.	The	blood	pressure	was	116/55	mmHg	and	the	respiratory	rate	was	20	per	minute	with	clear	breathing	sounds.	The	sclera	was	not	
icteric. 
A	routine	blood	test	showed	white	blood	cells	at	3,000/µl,	thrombocytes	at	187,000/µl,	haemoglobin	of	3.6	g/dl,	mean	corpuscular	volume	
(MCV)	of	65.6	fl	and	red	cell	distribution	width	of	38.5%.	Biochemical	evaluation	revealed	uric	acid	at	7.8	mg/ml,	fasting	plasma	sugar	at	
106	mg/ml	and	normal	liver	and	renal	function.	Interestingly,	A
1C
	was	only	4.6%	(reference	range	4.8%–6.0%).	The	serum	iron	concentration	
was	157	µg/dl	(reference	33–193),	total	iron	binding	capacity	was	183	µg/dl	(reference	245–419)	and	ferritin	levels	were	1,423.06	ng/ml	
(reference	21.81–274.66).	Antibodies	against	hepatitis	B	virus	surface	antigen	were	positive	and	antibodies	against	hepatitis	C	virus	were	
negative.	Alpha-fetoprotein,	carcinoembryonic	antigen,	cancer	antigen	19-9	and	prostate	specific	antigen	were	all	within	normal	 limits.	
Occult blood in stool and urine samples was negative. There was also no microhaematuria.
A sonogram of the abdomen found essentially normal biliary trees, mild coarsening of liver parenchyma, compatible with chronic parenchymal 
liver disease, and splenomegaly. Upper gastrointestinal tract endoscopy disclosed mild mucosal hyperaemia and some erosion over the 
antrum without active bleeding foci. 
The patient’s general condition improved to a great extent after red blood cell transfusion therapy. Nonetheless, tracing his medical record 
led	to	the	finding	of	an	at	least	10-year-long	history	of	persistent	microcytic	anaemia	frequently	rescued	with	red	blood	cell	transfusions.	
Furthermore, A
1C
 values constantly below the lower reference limit accompanying sometimes slightly elevated fasting plasma sugar levels 
in the past 5 months were noted (Table 1). Importantly, the patient had never had symptoms related to hypoglycaemic attacks.
 
Table 1. Fasting plasma sugar levels and corresponding haemoglobin A1C values
To investigate the cause of the incompatibility between the A
1C
 and blood sugar levels, haemoglobin H (HbH) staining using brilliant cresyl 
blue and haemoglobin electrophoresis were carried out. Unsurprisingly, many erythrocytes containing golf ball inclusions appeared in the 
HbH staining smear (Fig. 1).	Furthermore,	a	small	HbH	peak	was	detected	following	haemoglobin	electrophoresis,	estimated	to	occupy	6.2%	
of the total haemoglobin content (Fig. 2). Thus, HbH disease, a moderately severe form of alpha thalassaemia with 3 silent alpha globin genes, 
was diagnosed to be the underlying cause of the falsely low A
1C
. 
DISCUSSION
Although	the	main	differential	diagnoses	of	microcytic	anaemia	include	iron	deficiency	and	thalassaemia,	iron	deficiency	can	definitely	be	
ruled out based on a high serum ferritin level, low total iron binding capacity and no evidence of blood loss in this patient. In addition, 
many previous studies have found that the level of A
1C
	is	usually	falsely	increased	rather	than	falsely	decreased	in	iron	deficiency[2], further 
supporting thalassaemia as a more likely diagnosis.
Date 2019 Haemoglobin
(g/dl)
MCV (fl) Fasting Sugar 
(mg/ml)
HbA1c (%) 
Reference Range 
4.8–6.0
May 2 8.3 69.5 102 4.6
Jun 1 6.1 70.3 122 4.7
Jun 21 8.4 77.0 88 4.5
Sep 11 3.6 65.6 106 4.6
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Clinically,	 a	 rapid	 and	 confident	 diagnosis	 of	 alpha	 thalassaemia	 often	 relies	 on	 brilliant	 cresyl	 blue	 staining	 because	HbH	 is	 unstable	
and tends to decay during haemoglobin electrophoresis[3].	Hence,	the	patient’s	measurement	of	6.2%	HbH	may	also	be	underestimated.	
However, we are glad to uncover an obvious mystery hiding behind a paradoxical phenomenon.
Despite a former case report providing evidence that falsely high A
1C
 could be observed when HbH was superimposed onto the A
1C
 peak in 
ion exchange high pressure liquid chromatography analysis[4], a recent investigation concluded that A
1C
	values	were	significantly	lower	in	
patients with HbH disease than in control individuals and patients with only 1 or 2 silent alpha globin genes[5]. The opposite results seem to 
stem from different analytic devices used. 
In conclusion, physicians must be aware of the potential interference from haemoglobinopathies with enhanced erythrocyte destruction in 
A
1C
 measurement among individuals from an endemic area for thalassaemia.
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Figure 1. Haemoglobin H staining with brilliant cresyl blue. Arrows: erythrocytes 
with golf ball inclusions
Figure 2. Haemoglobin electrophoresis chromatography. Haemoglobin A 92.1%, 
haemoglobin A2 1.7%, haemoglobin H 6.2%
